It was reported that during a stent implantation procedure in superficial femoral artery, the stent allegedly ruptured in vivo after being released.It was further reported that the stent was not removed from patient's body, and a high-pressure balloon was used to dilation then the operation was completed.There was no reported patient injury.
|
The catalog number has not been cleared in the us but is similar to the lifestent xl vascular stent system products that are cleared in the us.The pro code and 510 k number for the lifestent xl vascular stent system products are identified.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.However, images were provided for review.The investigation of the reported event is currently underway.Expiry date: 09/2023.
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestent xl vascular stent system products that are cleared in the us.The pro code and 510 k number for the lifestent xl vascular stent system products are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the delivery system was not available for evaluation.X ray images provided demonstrates the deployed stent appearing like an hour glass which confirms stent twist.Strut fracture cannot be confirmed because single struts are not visible.The vessel was not tortuous/ calcified, the lesion was pre dilated, and a 0.018" guidewire with 6f sheath was used for access; the system was correctly held at the introducer, torque was not exerted nor felt, and the user did not experience difficulty during deployment.Based on the investigation of the provided information, the investigation is closed as confirmed for stent twisting.A definitive root cause could not be determined based upon the available information.Labeling review: in reviewing the relevant labeling for this product, the potential issue was found addressed.The instructions for use closely describes holding and handling of the system during deployment; in particular the instructions for use state: 'confirm that the introducer sheath is secure and will not move during deployment.(¿) to ensure the most accurate placement, firmly hold the black system stability sheath throughout deployment.(¿) do not hold the silver stent delivery sheath at any time during deployment.Do not constrict the stent delivery sheath during stent deployment.Initiate stent deployment by rotating the thumbwheel in the direction of the arrows, while holding the handle in a fixed position.' regarding pta the instructions for use state: 'predilation of the lesion should be performed using standard techniques.' regarding access and accessories, the instructions for use states: 'gain femoral access utilizing a 6f (2.0 mm) or larger introducer sheath.Insert a 0.035inch (0.89 mm) diameter guidewire of appropriate length (.)'.H10: d4 (expiry date: 09/2023), g3.H11: h6 (method, result, conclusion).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
It was reported that during a stent implantation procedure in superficial femoral artery, the stent allegedly ruptured in vivo after being released.It was further reported that the stent was not removed from patient's body, and a high-pressure balloon was used to dilation then the operation was completed.There was no reported patient injury.
|